ASAHI INTECC CO., LTD. Asahi Intecc Co., Ltd. and Cuorips Inc. (hereinafter "Cuorips") entered into a joint research agreement on a new therapeutic technology for regenerative medicine in April 2022, and both companies have been conducting research and development.
The development of catheters and injected cells have progressed smoothly and have advanced to the stage of non-clinical testing.
We are pleased to announce that we have reached an additional agreement as a result of discussions between the two companies with a view to future development.
For more information, please see the Cuorips press release page.( In Japanese only)
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Asahi Intecc Co. Ltd. published this content on 04 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 October 2023 08:23:03 UTC.
